Abiomed, Inc. (Nasdaq: ABMD) reported preliminary fourth quarter fiscal 2013 revenue of $43.7 million, up 17% compared to revenue of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE